Glioblastoma Clinical Trials in Glendale, AZ

Glioblastoma Clinical Trials in Glendale, AZ

View the best 10 glioblastoma medical studies in Glendale, Arizona. Access promising new therapies by applying to a Glendale-based Glioblastoma clinical trial.

Trials in Glendale, Arizona

Here are the top 10 medical studies for glioblastoma in Glendale, Arizona

Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Barrow Neurological Institute (SJHMC) in Phoenix, United States.

Intraoperative radiotherapy

Recruiting2 awardsPhase 3
This trial is testing if adding intraoperative radiotherapy (IORT) to standard radiochemotherapy can improve the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM).
Image of Children's Hospital of Alabama in Birmingham, United States.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Image of Vidant Health in Greenville, United States.

GammaTile radiation therapy implantation +3 More

Brachytherapy

Recruiting3 awardsPhase 4
This trial tests if adding GammaTile radiation therapy to standard treatment can improve outcomes for patients with newly diagnosed GBM. GammaTile delivers quick, direct radiation to the tumor, which may help control the tumor better and improve survival rates.
Image of Mayo Clinic in Rochester in Rochester, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is testing pembrolizumab in combination with standard therapy (temozolomide and radiation therapy) to see if it can help treat patients with glioblastoma by killing tumor cells.
Image of City of Hope Comprehensive Cancer Center LAO in Duarte, United States.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Recruiting1 awardPhase 1 & 2
This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.
Image of Mayo Clinic in Phoenix, United States.

Retifanlimab +3 More

Immune Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing a combination of treatments including a new drug, radiation therapy, and other medications for patients with aggressive brain cancer that has returned. The goal is to boost the body's immune system to better fight the cancer, shrink tumors, and help patients live longer.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.